BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 36715072)

  • 1. What accounts for the different regional responses to COVID-19 in China? Exploring the role of institutional environment, governance capacity and legitimacy.
    Mao Y
    Health Policy Plan; 2023 Apr; 38(4):552-566. PubMed ID: 36715072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 3. Why do democracies respond differently to COVID-19? A comparison of the United States and South Korea.
    Mao Y
    Front Public Health; 2023; 11():1285552. PubMed ID: 38288425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in China: Power, Transparency and Governance in Public Health Crisis.
    Zhang J; Zhang R
    Healthcare (Basel); 2020 Aug; 8(3):. PubMed ID: 32842607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balancing Governance Capacity and Legitimacy: How the Norwegian Government Handled the COVID-19 Crisis as a High Performer.
    Christensen T; Lægreid P
    Public Adm Rev; 2020; 80(5):774-779. PubMed ID: 32836445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Governance and planning in a 'perfect storm': Securitising climate change, migration and Covid-19 in Sweden.
    Elander I; Granberg M; Montin S
    Prog Plann; 2022 Oct; 164():100634. PubMed ID: 36217494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the Characteristics of Policies and Political Institutions for the Prevention and Control Governance of the COVID-19 Pandemic: Evidence from China.
    Dong M; Zhou C; Zhang Z
    Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policymaking in a low-trust state: legitimacy, state capacity, and responses to COVID-19 in Hong Kong.
    Hartley K; Jarvis DSL
    Policy Soc; 2020 Sep; 39(3):403-423. PubMed ID: 35039728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community Resilience Governance on Public Health Crisis in China.
    Wang C; Dong X; Zhang Y; Luo Y
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33671618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Institutional Network Relationship of Chinese Public Crisis Governance System-Based on the Quantitative Comparative Analysis of Policies during SARS and COVID-19.
    Yang J; Huang W
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citizens' Adherence to COVID-19 Mitigation Recommendations by the Government: A 3-Country Comparative Evaluation Using Web-Based Cross-Sectional Survey Data.
    Al-Hasan A; Yim D; Khuntia J
    J Med Internet Res; 2020 Aug; 22(8):e20634. PubMed ID: 32716896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Citizen Engagement With Government Social Media Accounts Differ During the Different Stages of Public Health Crises? An Empirical Examination of the COVID-19 Pandemic.
    Zhang W; Yuan H; Zhu C; Chen Q; Evans R
    Front Public Health; 2022; 10():807459. PubMed ID: 35774579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whether Social Participation Can Affect the Central Government Public Policy Response to the COVID-19 in China.
    Fu L; Sun H; Xu K
    Front Public Health; 2022; 10():842373. PubMed ID: 35570925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Caused the Outbreak of COVID-19 in China: From the Perspective of Crisis Management.
    Shangguan Z; Wang MY; Sun W
    Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32397199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccination and governance in the case of low, middle and high-income countries.
    Lupu D; Tiganasu R
    BMC Public Health; 2023 Jun; 23(1):1073. PubMed ID: 37277743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of the Chinese Government's Efforts to Fight COVID-19: Integration of Top-Down Interventions and Local Governance.
    Gao J; Zhang P
    Health Secur; 2022; 20(4):348-356. PubMed ID: 35787156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative neighborhood governance and its effectiveness in community mitigation to COVID-19 pandemic: From the perspective of community workers in six Chinese cities.
    Liu Z; Lin S; Shen Y; Lu T
    Cities; 2021 Sep; 116():103274. PubMed ID: 36471788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Publicity governance in contingency management during the COVID-19 pandemic in China: A "Government-Society" perspective.
    Wang M; Peng X
    PLoS One; 2023; 18(11):e0293210. PubMed ID: 37948395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 in China: Responses, Challenges and Implications for the Health System.
    Xing C; Zhang R
    Healthcare (Basel); 2021 Jan; 9(1):. PubMed ID: 33466996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the influence of institutions, politics, organizations, and governance on the COVID-19 response in British Columbia, Canada: a jurisdictional case study protocol.
    Brubacher LJ; Hasan MZ; Sriram V; Keidar S; Wu A; Cheng M; Lovato CY; ; Berman P
    Health Res Policy Syst; 2022 Jun; 20(1):74. PubMed ID: 35729534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.